Friess Associates’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-197,970
Closed -$18.6M 100
2020
Q4
$18.6M Buy
+197,970
New +$17.4M 1.37% 45
2014
Q4
Sell
-223,500
Closed -$17.3M 147
2014
Q3
$17.3M Buy
+223,500
New +$17.3M 1.48% 32

Other funds holding CRI

Friess Associates's CRI Position: Q1 2021 in Review

Friess Associates sold out of Carter's (CRI) in Q1 2021, closing a stake of 197,970 shares — an estimated $18.6M sold.

Friess Associates first reported a position in CRI in Q3 2014 and held it in 2 quarters. The position peaked at $18.6M in Q4 2020. 300 funds tracked by Wall St. Rank hold CRI as of Q1 2021.

  • Friess Associates reported no remaining Carter's position as of Q1 2021 after selling out during the quarter.
  • Friess Associates sold 197,970 Carter's shares in Q1 2021, an estimated $18.6M.
  • Friess Associates first reported a position in Carter's in Q3 2014 and held it in 2 quarters.
  • Friess Associates's Carter's position peaked at $18.6M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Carter's as of Q1 2021.

Based on Friess Associates's 13F filing for Q1 2021, filed 14 May 2021.